JUN 16, 2020 10:06 AM PDT

Wearable patch for melanoma patients

Research published in the journal ACS Nano describes a wearable patch that can be used to lessen side effects from chemotherapy and radiotherapy for melanoma patients. The innovation was created by researchers at Purdue University in response to the suffering that melanoma patients undergo when receiving conventional therapies to fight the cancer. 

Melanoma is an aggressive kind of skin cancer that can metastasize quickly if it is not treated early. Additionally, it is a particularly tricky cancer because melanoma cells are known for being recurrent in their nature.

"We developed a novel wearable patch with fully miniaturized needles, enabling unobtrusive drug delivery through the skin for the management of skin cancers," said Chi Hwan Lee, who is a Purdue assistant professor of biomedical engineering and mechanical engineering. "Uniquely, this patch is fully dissolvable by body fluids in a programmable manner such that the patch substrate is dissolved within one minute after the introduction of needles into the skin, followed by the gradual dissolution of the silicon needles inside the tissues within several months."

The bioresorbable silicon nanoneedles are constructed on a thin, flexible and water-soluble medical film which is used to insert the needles. The silicon nanoneedles dissolve quickly into the skin afterward but because they stay active over time, the patch provides delivery of anti-cancer drugs for  an extended period. Eventually, the biocompatible nanoneedles dissolve in into tissue fluids and reabsorb into the body without any adverse secondary effects. 

"The uniqueness of our technology arises from the fact that we used extremely small but long-lasting silicon nanoneedles with sharpened angular tips that are easy for their penetration into the skin in a painless and minimally invasive manner," Lee said.

The patch will provide more comfort to melanoma patients than conventional treatment options. Photo: Pixabay

Compared to conventional microneedles, the nanoneedles’ pore surface areas are able to provide a large drug loading capacity, which Lee says can target melanoma sites to deliver chemotherapeutic drugs. 

Following Eureka Alert, Lee said he got inspired to create such an innovation after observing how scared his daughter was of needles when receiving vaccinations.

Sources: ACS Nano, Eureka Alert

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 12, 2022
Cancer
Crisis in Ukraine Disrupts Delivery of Critical Cancer Care
MAY 12, 2022
Crisis in Ukraine Disrupts Delivery of Critical Cancer Care
Many factors including the type of cancer, pathologic stage, and the general health and demographics of the patient, dic ...
MAY 16, 2022
Cancer
"Pawsitive" Effects of Pet Therapy
MAY 16, 2022
"Pawsitive" Effects of Pet Therapy
  Over the past couple of months, we have explored art and music therapies, two types of alternative therapeutic ap ...
JUN 06, 2022
Immunology
Using Antibodies to Create Potent Cancer Treatments
JUN 06, 2022
Using Antibodies to Create Potent Cancer Treatments
Cancer can arise from a variety of aberrations that cause cells to divide uncontrollably, and form a tumor. The causes o ...
JUN 20, 2022
Cancer
Uterine Cancer Mortality is on the Rise
JUN 20, 2022
Uterine Cancer Mortality is on the Rise
Uterine cancer develops when cells in the inner lining of the uterus, known as the endometrium, undergo uncontrolled and ...
JUL 25, 2022
Cancer
Does the Secret to Immunotherapy Lie in...Poop?
JUL 25, 2022
Does the Secret to Immunotherapy Lie in...Poop?
Advancements in immunotherapy have proven instrumental in reshaping the face of cancer research in recent years.  W ...
SEP 26, 2022
Cancer
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
SEP 26, 2022
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...
Loading Comments...